Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea
· Delayed Price · Currency is KRW 15,410
+160 (1.05%)
At close: Mar 9, 2026
Hyundai Bioscience Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,479,922 | 561,851 | 1,038,982 | 1,087,244 | 976,101 | 1,048,678 | Upgrade
|
| Market Cap Growth | 200.21% | -45.92% | -4.44% | 11.39% | -6.92% | 115.45% | Upgrade
|
| Enterprise Value | 1,450,563 | 579,143 | 1,031,571 | 1,069,527 | 969,321 | 1,050,097 | Upgrade
|
| Last Close Price | 15410.00 | 7055.00 | 12295.97 | 12908.41 | 11895.53 | 13756.41 | Upgrade
|
| PS Ratio | 754.95 | 37.33 | 109.58 | 138.48 | 105.62 | 83.82 | Upgrade
|
| PB Ratio | 13.42 | 14.25 | 22.95 | 18.67 | 15.85 | 20.04 | Upgrade
|
| P/TBV Ratio | 25.47 | 89.63 | 73.68 | 43.38 | 34.98 | 81.02 | Upgrade
|
| P/FCF Ratio | - | 269.15 | - | - | - | - | Upgrade
|
| P/OCF Ratio | - | 248.93 | - | - | - | 139.79 | Upgrade
|
| EV/Sales Ratio | - | 38.48 | 108.80 | 136.22 | 104.89 | 83.93 | Upgrade
|
| EV/EBITDA Ratio | - | 406.48 | - | - | - | - | Upgrade
|
| EV/EBIT Ratio | - | 732.19 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | -40.96 | 277.44 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.67 | 0.12 | 0.11 | 0.25 | 0.71 | Upgrade
|
| Debt / EBITDA Ratio | - | 18.66 | - | - | - | - | Upgrade
|
| Debt / FCF Ratio | - | 12.74 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.27 | 0.58 | -0.14 | -0.21 | -0.11 | 0.34 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.91 | 16.10 | 0.75 | 0.51 | 1.02 | -27.48 | Upgrade
|
| Net Debt / FCF Ratio | 0.83 | 10.99 | 0.96 | 0.69 | 1.57 | -1.01 | Upgrade
|
| Asset Turnover | 0.02 | 0.25 | 0.16 | 0.11 | 0.11 | 0.16 | Upgrade
|
| Inventory Turnover | 1.44 | 1.78 | 1.62 | 1.63 | 1.59 | 1.19 | Upgrade
|
| Quick Ratio | 5.94 | 0.14 | 1.77 | 2.23 | 1.73 | 3.41 | Upgrade
|
| Current Ratio | 6.40 | 0.25 | 2.18 | 2.67 | 2.02 | 4.37 | Upgrade
|
| Return on Equity (ROE) | -28.52% | -16.36% | -28.02% | -26.39% | -35.21% | -16.50% | Upgrade
|
| Return on Assets (ROA) | -11.01% | 0.82% | -10.20% | -22.24% | -6.66% | -3.51% | Upgrade
|
| Return on Invested Capital (ROIC) | -20.25% | 1.56% | -23.13% | -52.30% | -14.85% | -7.12% | Upgrade
|
| Return on Capital Employed (ROCE) | -14.90% | 2.00% | -21.40% | -45.10% | -14.70% | -5.30% | Upgrade
|
| Earnings Yield | -1.48% | -1.23% | -1.40% | -1.45% | -2.05% | -0.79% | Upgrade
|
| FCF Yield | -2.39% | 0.37% | -0.63% | -1.66% | -0.44% | -1.69% | Upgrade
|
| Buyback Yield / Dilution | -140.29% | -0.10% | -1.04% | -6.64% | -2.79% | -3.67% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.